About coramaze
Coramaze Technologies develops an innovative, highly differentiated, transcatheter tricuspid valve repair system, called TriPair. Headquartered in Germany with an R&D hub in Israel, we promote health equity by offering a solution that is easy to use, fast, and effective. We empower physicians in both existing and new markets, allowing them to treat patients who cannot be served with existing technologies.
Press releases
Press
coramaze technologies raises EUR 4.5 million to advance novel transfemoral mitral valve repair system into the clinic
mitramaze® – First transfemoral mitral valve repair system with atraumatic anchoring being developed
coramaze technologies GmbH, a German medical device company, is developing the mitramaze® valve repair system – a novel concept for transcatheter mitral valve repair (TMVRep) intended for treatment of inoperable patients suffering from severe functional mitral regurgitation (fMR). coramaze announced today the closing of a EUR 4.5 million (US$ 5.15 million) series A financing round led by
Press
coramaze technologies GmbH receives € 1 million to develop an innovative medical device for the minimally invasive treatment of heart valve diseases
coramaze technologies GmbH, a German company founded and based in Essen as a spin-off from the Western German Heart Center, is developing an innovative medical device for the minimally invasive treatment of one of the most common structural heart valve diseases, mitral regurgitation. The mitramaze® valve repair system technology has been developed through a technological research project funded by the EXIST research transfer of the German Federal Ministry of Economics and Technology. The compan
Info & Contact
Address
Mühlenhof 7-9
40721 Hilden
40721 Hilden
In portfolio
06. Feb 2014
Sector
Dr. Anke Caßing
Principal / Authorized Signatory